AlloVir, Inc. - Common Stock (ALVR)
9.4200
+0.0100 (0.11%)
Allovir Inc is a biotechnology company focused on developing innovative cell therapies aimed at treating viral infections in immunocompromised patients
The company leverages its proprietary technology platform to produce potential therapies that can enhance the immune response against viral pathogens, particularly in individuals with weakened immune systems, such as those undergoing stem cell transplants or other forms of immunosuppression. By harnessing the power of T-cells, Allovir aims to provide effective treatment options for viral infections that currently have limited therapeutic alternatives, ultimately improving patient outcomes and quality of life.
Frequently Asked Questions
Is AlloVir, Inc. - Common Stock publicly traded?
Yes, AlloVir, Inc. - Common Stock is publicly traded.
What exchange does AlloVir, Inc. - Common Stock trade on?
AlloVir, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for AlloVir, Inc. - Common Stock?
The ticker symbol for AlloVir, Inc. - Common Stock is ALVR on the Nasdaq Stock Market
What is the current price of AlloVir, Inc. - Common Stock?
The current price of AlloVir, Inc. - Common Stock is 9.420
When was AlloVir, Inc. - Common Stock last traded?
The last trade of AlloVir, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of AlloVir, Inc. - Common Stock?
The market capitalization of AlloVir, Inc. - Common Stock is 1.07B
How many shares of AlloVir, Inc. - Common Stock are outstanding?
AlloVir, Inc. - Common Stock has 113.87M shares outstanding.